Curtis Consult primarily works with life sciences companies — biotech, specialty pharma and mid-cap companies with complex scientific data and investor-facing needs. The focus is on companies preparing for or going through critical events such as IPOs, clinical data announcements, M&A or leadership changes.

Curtis Consult provides senior, strategic advisory rather than execution-level PR services. Rachel works directly with leadership teams as a trusted advisor, bringing deep sector expertise and capital markets understanding. The focus is on clarity, credibility and strategic positioning.

Engagements are tailored to each company’s needs. This can range from short-term project-based advisory around specific events (IPO, data readouts) to longer-term strategic counsel. Every engagement begins with understanding the company’s situation and objectives.

Absolutely. With decades of international experience across the US, UK, Europe and the Nordics, and native English as a mother tongue, Curtis Consult is well positioned to support companies communicating across borders and with international investor audiences. This can range from shortterm project-based advisory around specific events (for example IPO, data readouts, change projects) to longer-term strategic counsel. Every engagement begins with understanding the company’s situation and objectives.

An initial conversation is informal and exploratory — an opportunity to discuss your situation, challenges and objectives. There is no commitment required. It’s about understanding whether Curtis Consult is the right fit for your needs.